小RNA
癌变
生物发生
核糖核酸
癌症干细胞
癌细胞
癌症
基因
干细胞
基因表达
基因表达调控
生物
癌症研究
计算生物学
细胞生物学
化学
遗传学
作者
Chloé Maucort,Maurinne Bonnet,Jean‐Claude Ortuno,Gordon C. Tucker,Emie Quissac,Maïté Verreault,Stéphane Azoulay,Christophe Di Giorgio,Audrey Di Giorgio,Maria Duca
标识
DOI:10.1021/acs.jmedchem.3c00797
摘要
Noncoding RNAs (ncRNAs) play pivotal roles in the regulation of gene expression and represent a promising target for the development of new therapeutic approaches. Among these ncRNAs, microRNAs (miRNAs or miRs) are involved in the regulation of gene expression, and their dysregulation has been linked to several diseases such as cancers. Indeed, oncogenic miRNAs are overexpressed in cancer cells, thus promoting tumorigenesis and maintenance of cancer stem cells that are resistant to chemotherapy and often responsible for therapeutic failure. Here, we describe the design and synthesis of new small-molecule RNA binders able to inhibit the biogenesis of oncogenic miRNAs and target efficiently cancer stem cells. Through the biochemical study of their interaction with the target and thanks to intracellular assays, we describe the structure–activity relationships for this new series of RNA ligands, and we identify compounds bearing a very promising antiproliferative activity against cancer stem cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI